Brain Tumor Therapeutics: Global Markets to 2023

Jan 2019| PHM208A| BCC Publishing

Report Highlights

The global market for brain tumor therapeutics should grow from $1.1 billion in 2018 to reach $2.0 billion by 2023 at a compound annual growth rate (CAGR) of 12.9% for the period of 2018-2023.

Report Includes

  • 20 data tables and 40 additional tables
  • Comprehensive overview of the global market for brain tumor therapeutics within the pharmaceutical industry
  • Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Country specific data and analysis for United States, Canada, Mexico, Japan, China, India, France, Germany, U.K., Italy, Spain and Middle East and Africa
  • Impact analysis of major drivers and restraints, and regional dynamics of the global brain tumor therapeutics markets and current trends within the industry
  • Company profiles of prominent players in the market, including Bristol-Myers Squibb Co., Eisai Co., Ltd., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., and Novartis International AG

Report Scope

This report provides an overview of the current and future global market potential for brain tumor therapeutics. It provides a detailed analysis and information about conventional treatment options, ongoing market trends and the future direction of the market with respect to brain tumor therapy. 


  • The report covers a detailed background of the disease state, along with epidemiological and demographic data, market segmentation by therapy (chemotherapy and targeted therapy), age group of patients (adult and pediatric brain tumors), end users (hospitals, cancer research institutes and medical universities) and a detailed regional market analysis including North America, Europe, Asia-Pacific and the rest of the world. 
  • The report provides information on newer treatment opportunities and cutting-edge research on therapeutics for brain tumors. It covers various types of treatment used in the field of neuro-oncology: surgery, chemotherapy, radiotherapy, targeted therapy and immunotherapy. 
  • A detailed analysis of agents used in the market for chemotherapy, immunotherapy and targeted therapy, as well as a pipeline analysis of newer molecules and therapeutics is covered in the report. 
  • A comprehensive analysis of market dynamics in the industry and current market trends are described in the report, along with the competitive landscape and discussion about key market players in the field of brain tumor therapeutics, where market strategies of these players are studied and described. The report includes a patent analysis of brain tumor therapeutics. 
  • The report concludes with company profiles of key players in the development and commercialization of brain tumor therapeutics. 
  • A separate chapter on emerging trends and breakthrough technologies in the field of neuro-oncology has been included in this report. 


Excluded from this report are the market size for equipment used in radiotherapy, surgical equipment and supplies and market size for drugs used for the symptomatic management of cancer (anti-epileptics, anti-emetics and hormonal medications). This report also excludes market size for immunotherapy. This is not a proven treatment for brain tumors and is currently being developed in research and clinical trials. 

Market values are provided for 2017 as base year, 2018 and forecast through 2023.Estimated values are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Latest reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesPrice Member Price
Full Report: Brain Tumor Therapeutics: Global Markets to 2023161 $2,750 Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Disease Background and Overview24$415Free
Chapter- 4: Market Dynamics12$208Free
Chapter- 5: Market Breakdown by Therapy22$381Free
Chapter- 6: Market Breakdown by Patient Age14$242Free
Chapter- 7: Market Breakdown by End User5$86Free
Chapter- 8: Market Breakdown by Region14$242Free
Chapter- 9: Emerging Technologies and Future Trends6$104Free
Chapter- 10: Clinical Research in Brain Tumor Therapeutics9$156Free
Chapter- 11: Patent Review5$86Free
Chapter- 12: Competitive Landscape and Market Strategies9$156Free
Chapter- 13: Regulatory and Reimbursement Landscape10$173Free
Chapter- 14: Company Profiles21$363Free
Chapter- 15: Appendix: Acronyms2$35Free
Brain Tumor Therapeutics: Global Markets to 2023

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries